Loading clinical trials...
Loading clinical trials...
Evaluation of Compass: A Group Clinical Program in Psycho-Oncology Using Acceptance and Commitment Therapy to Address Fear of Recurrence/Progression in Cancer Survivors
Conditions
Interventions
Acceptance and Commitment Therapy
Questionnaires
Locations
1
United States
University of California, San Francisco
San Francisco, California, United States
Start Date
March 24, 2020
Primary Completion Date
December 14, 2020
Completion Date
December 14, 2020
Last Updated
December 17, 2020
NCT05468034
NCT04541381
NCT02600949
NCT05398783
NCT06043817
NCT07446322
Lead Sponsor
University of California, San Francisco
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions